Net profit of Sun Pharmaceutical Industries declined 19.64% to ₹ 2278.63 crore in the quarter ended June 2025 as against ₹ 2835.62 crore during the previous quarter ended June 2024. Sales rose 10.07% to ₹ 13786.07 crore in the quarter ended June 2025 as against ₹ 12524.51 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 13786.07 | 12524.51 | 10 |
| OPM % | 31.20 | 28.80 | - |
| PBDT | 4691.32 | 4078.63 | 15 |
| PBT | 3990.77 | 3423.50 | 17 |
| NP | 2278.63 | 2835.62 | -20 |